Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sima Jeha, MD
St. Jude Children's Research Hospital
Principal Investigator - Tanja Gruber, MD, PhD
Lucile Packard Children's Hospital Stanford University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- Stollery Children'S Hospital
Edmonton, Alberta, Canada
- Children'S & Women'S Health Centre of British Columbia
Vancouver, British Columbia, Canada
- Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
- the Montreal Children'S Hospital (muhc-Mcgill)
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Quebec, Canada
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- Children'S Hospital and Clinics of Minnesota
Minneapolis, Minnesota, United States
- St. Jude Affiliate-Charlotte
Charlotte, North Carolina, United States
- Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Children'S Hospital of the King'S Daughters (chkd)
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Jan 2016
- Primary completion
- 10 May 2022
- Completion
- 31 Oct 2031
- Last update posted
- 24 Jun 2026
- Registered enrollment
- 50
- Registry id
- NCT02553460
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.